Michael Chen

Michael Chen is a senior financial analyst and investment researcher with over 15 years of experience covering global equity markets. He specializes in technology sector analysis, fundamental valuation, and macroeconomic trends affecting institutional portfolios.

Equity ResearchFinancial ModelingSEC Filings AnalysisTechnology StocksMacroeconomic AnalysisValuation MethodsEarnings AnalysisRisk AssessmentPortfolio ManagementESG Investing

219 published articles • Page 15

Articles by Michael Chen

Analyst Upgrade Reports: How to Verify the Intel and AMD Thesis

Analyst Upgrade Reports: How to Verify the Intel and AMD Thesis

A practical workflow to validate “memory supercycle” and data center demand claims using filings, searchable notes, and repeatable dashboards

Delta earnings: what the quarter says about premium demand in 2026

Delta earnings: what the quarter says about premium demand in 2026

A practical framework to read the print, the guide, and the fleet moves using Alpha Analyst

JPMorgan earnings recap: Q4 beat, trading strength, and what to track next

JPMorgan earnings recap: Q4 beat, trading strength, and what to track next

A practical checklist for interpreting bank results—and how to turn the quarter into ongoing monitoring in Alpha Analyst

L3Harris missile business IPO plan: what to monitor in 2026

L3Harris missile business IPO plan: what to monitor in 2026

A practical, filing-first checklist for tracking a proposed carve-out, DoD partnership signals, and investor catalysts

Exxon Mobil (XOM) and Venezuela: What Trump’s Warning Changes

Exxon Mobil (XOM) and Venezuela: What Trump’s Warning Changes

A timely risk brief for energy investors on access, sanctions, and deal durability

Sun Country–Allegiant Deal: A Research Playbook for Investors

Sun Country–Allegiant Deal: A Research Playbook for Investors

How to track terms, filings, synergies, and risks for the SNCY acquisition (and what to monitor next)

Abivax takeover rumor: how to research it like an analyst

Abivax takeover rumor: how to research it like an analyst

A practical checklist for validating biotech M&A chatter and tracking the next confirming signals